{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T15:58:20Z","timestamp":1792425500619,"version":"4.5.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T00:00:00Z","timestamp":1765756800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T00:00:00Z","timestamp":1767830400000},"content-version":"vor","delay-in-days":24,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-30454-y","type":"journal-article","created":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T14:49:21Z","timestamp":1765810161000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["New insights into the mechanism of microvascular rarefaction via endothelial-mesenchymal transition in steroid-induced osteonecrosis of femoral head"],"prefix":"10.1038","volume":"16","author":[{"given":"Xiaoqiang","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaru","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mincong","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziqi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiushi","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,15]]},"reference":[{"key":"30454_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtauto.2022.100168","volume":"5","author":"F Motta","year":"2022","unstructured":"Motta, F., Timilsina, S., Gershwin, M. E. & Selmi, C. Steroid-induced osteonecrosis. J Transl Autoimmun. 5, 100168 (2022).","journal-title":"J Transl Autoimmun."},{"key":"30454_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2020.102460","volume":"110","author":"C Chang","year":"2020","unstructured":"Chang, C., Greenspan, A. & Gershwin, M. E. The pathogenesis, diagnosis and clinical manifestations of steroid-induced osteonecrosis. J Autoimmun. 110, 102460 (2020).","journal-title":"J Autoimmun."},{"key":"30454_CR3","doi-asserted-by":"publisher","first-page":"983","DOI":"10.2147\/DDDT.S298691","volume":"15","author":"S Zhang","year":"2021","unstructured":"Zhang, S., Wang, C., Shi, L. & Xue, Q. Beware of steroid-induced avascular necrosis of the femoral head in the treatment of COVID-19-experience and lessons from the SARS epidemic. Drug Des Devel Ther. 15, 983\u2013995 (2021).","journal-title":"Drug Des Devel Ther."},{"key":"30454_CR4","first-page":"7928","volume":"16","author":"J Chen","year":"2024","unstructured":"Chen, J. et al. Human umbilical cord mesenchymal stem cells promote steroid-induced osteonecrosis of the femoral head repair by improving microvascular endothelial cell function. Aging 16, 7928\u20137945 (2024).","journal-title":"Aging"},{"key":"30454_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2020.145128","volume":"766","author":"J Yue","year":"2021","unstructured":"Yue, J. et al. Preliminary study of icariin indicating prevention of steroid-induced osteonecrosis of femoral head by regulating abnormal expression of miRNA-335 and protecting the functions of bone microvascular endothelial cells in rats. Gene 766, 145128 (2021).","journal-title":"Gene"},{"key":"30454_CR6","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41413-023-00259-8","volume":"11","author":"F Zhang","year":"2023","unstructured":"Zhang, F. et al. FAR591 promotes the pathogenesis and progression of SONFH by regulating Fos expression to mediate the apoptosis of bone microvascular endothelial cells. Bone Res. 11, 27 (2023).","journal-title":"Bone Res."},{"key":"30454_CR7","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.4103\/0366-6999.160564","volume":"128","author":"QS Yu","year":"2015","unstructured":"Yu, Q. S. et al. Glucocorticoids significantly influence the transcriptome of bone microvascular endothelial cells of human femoral head. Chin Med J (Engl). 128, 1956\u20131963 (2015).","journal-title":"Chin Med J (Engl)."},{"key":"30454_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4161\/org.6.1.10427","volume":"6","author":"MS Goligorsky","year":"2010","unstructured":"Goligorsky, M. S. Microvascular rarefaction: The decline and fall of blood vessels. Organogenesis 6, 1\u201310 (2010).","journal-title":"Organogenesis"},{"key":"30454_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.vph.2024.107393","volume":"156","author":"D Manning","year":"2024","unstructured":"Manning, D., Rivera, E. J. & Santana, L. F. The life cycle of a capillary: Mechanisms of angiogenesis and rarefaction in microvascular physiology and pathologies. Vascul Pharmacol. 156, 107393 (2024).","journal-title":"Vascul Pharmacol."},{"key":"30454_CR10","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1210\/endrev\/bnaa025","volume":"42","author":"WB Horton","year":"2021","unstructured":"Horton, W. B. & Barrett, E. J. Microvascular dysfunction in diabetes mellitus and cardiometabolic disease. Endocr Rev. 42, 29\u201355 (2021).","journal-title":"Endocr Rev."},{"key":"30454_CR11","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s11914-023-00841-3","volume":"22","author":"T Le","year":"2024","unstructured":"Le, T., Salas Sanchez, A., Nashawi, D., Kulkarni, S. & Prisby, R. D. Diabetes and the microvasculature of the bone and marrow. Curr Osteoporos Rep. 22, 11\u201327 (2024).","journal-title":"Curr Osteoporos Rep."},{"key":"30454_CR12","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1161\/HYPERTENSIONAHA.122.18085","volume":"80","author":"MM Santisteban","year":"2023","unstructured":"Santisteban, M. M., Iadecola, C. & Carnevale, D. Hypertension, neurovascular dysfunction, and cognitive impairment. Hypertension 80, 22\u201334 (2023).","journal-title":"Hypertension"},{"key":"30454_CR13","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3389\/fcvm.2019.00015","volume":"6","author":"H Zeng","year":"2019","unstructured":"Zeng, H. & Chen, J. X. Microvascular rarefaction and heart failure with preserved ejection fraction. Front Cardiovasc Med. 6, 15 (2019).","journal-title":"Front Cardiovasc Med."},{"key":"30454_CR14","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a041163","volume":"15","author":"Y Zeng","year":"2025","unstructured":"Zeng, Y. & Fu, B. M. Angiogenesis and microvascular permeability. Cold Spring Harb Perspect Med. 15, a041163 (2025).","journal-title":"Cold Spring Harb Perspect Med."},{"key":"30454_CR15","doi-asserted-by":"publisher","first-page":"C712","DOI":"10.1152\/ajpcell.00526.2023","volume":"326","author":"MS Goligorsky","year":"2024","unstructured":"Goligorsky, M. S. Permissive role of vascular endothelium in fibrosis: focus on the kidney. Am J Physiol Cell Physiol. 326, C712\u2013C723 (2024).","journal-title":"Am J Physiol Cell Physiol."},{"key":"30454_CR16","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/bs.apha.2016.04.007","volume":"77","author":"MS Goligorsky","year":"2016","unstructured":"Goligorsky, M. S. & Hirschi, K. Stress-induced premature senescence of endothelial and endothelial progenitor cells. Adv Pharmacol. 77, 281\u2013306 (2016).","journal-title":"Adv Pharmacol."},{"key":"30454_CR17","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1152\/physrev.00021.2018","volume":"99","author":"S Piera-Velazquez","year":"2019","unstructured":"Piera-Velazquez, S. & Jimenez, S. A. Endothelial to mesenchymal transition: Role in physiology and in the pathogenesis of human diseases. Physiol Rev. 99, 1281\u20131324 (2019).","journal-title":"Physiol Rev."},{"key":"30454_CR18","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1146\/annurev-physiol-032222-080806","volume":"85","author":"Y Xu","year":"2023","unstructured":"Xu, Y. & Kovacic, J. C. Endothelial to mesenchymal transition in health and disease. Annu Rev Physiol. 85, 245\u2013267 (2023).","journal-title":"Annu Rev Physiol."},{"key":"30454_CR19","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.1161\/ATVBAHA.121.313788","volume":"41","author":"Z Alvandi","year":"2021","unstructured":"Alvandi, Z. & Bischoff, J. Endothelial-mesenchymal transition in cardiovascular disease. Arterioscler Thromb Vasc Biol. 41, 2357\u20132369 (2021).","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"30454_CR20","doi-asserted-by":"publisher","first-page":"747","DOI":"10.3389\/fcell.2020.00747","volume":"8","author":"N Clere","year":"2020","unstructured":"Clere, N., Renault, S. & Corre, I. Endothelial-to-mesenchymal transition in cancer. Front Cell Dev Biol. 8, 747 (2020).","journal-title":"Front Cell Dev Biol."},{"key":"30454_CR21","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1093\/ndt\/gfad238","volume":"39","author":"ME Jacobs","year":"2024","unstructured":"Jacobs, M. E., de Vries, D. K., Engelse, M. A., Dumas, S. J. & Rabelink, T. J. Endothelial to mesenchymal transition in kidney fibrosis. Nephrol Dial Transplant. 39, 752\u2013760 (2024).","journal-title":"Nephrol Dial Transplant."},{"key":"30454_CR22","doi-asserted-by":"publisher","first-page":"e124","DOI":"10.1161\/ATVBAHA.122.318172","volume":"43","author":"S Nasim","year":"2023","unstructured":"Nasim, S. et al. CD45 is sufficient to initiate endothelial-to-mesenchymal transition in human endothelial cells: Brief report. Arterioscler. Thromb. Vasc. Biol. 43, e124\u2013e131 (2023).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"30454_CR23","doi-asserted-by":"publisher","first-page":"72","DOI":"10.52312\/jdrs.2023.1405","volume":"35","author":"O Beytemur","year":"2024","unstructured":"Beytemur, O., Dasci, M. F., Gok Yurttas, A., Bayrak, B. Y. & Alagoz, E. The protective role of vitamins C and E in steroid-induced femoral head osteonecrosis: An experimental study in rats. Jt Dis Relat Surg. 35, 72\u201384 (2024).","journal-title":"Jt Dis Relat Surg."},{"key":"30454_CR24","first-page":"887","volume":"17","author":"T Matsumoto","year":"2007","unstructured":"Matsumoto, T., Kitamura, K., Ichiseki, T., Kaneuji, A. & Sugimori, T. Oxidative stress on idiopathic osteonecrosis. Clin Calcium. 17, 887\u2013891 (2007).","journal-title":"Clin Calcium."},{"key":"30454_CR25","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1111\/os.14010","volume":"16","author":"X Zhang","year":"2024","unstructured":"Zhang, X. et al. Dexamethasone induced osteocyte apoptosis in steroid-induced femoral head osteonecrosis through ROS-mediated oxidative stress. Orthop Surg. 16, 733\u2013744 (2024).","journal-title":"Orthop Surg."},{"key":"30454_CR26","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.3389\/fimmu.2018.01985","volume":"9","author":"DTB Thuan","year":"2018","unstructured":"Thuan, D. T. B. et al. A potential link between oxidative stress and endothelial-to-mesenchymal transition in systemic sclerosis. Front Immunol. 9, 1985 (2018).","journal-title":"Front Immunol."},{"key":"30454_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2021.102120","volume":"46","author":"JA Pan","year":"2021","unstructured":"Pan, J. A. et al. Irisin ameliorates doxorubicin-induced cardiac perivascular fibrosis through inhibiting endothelial-to-mesenchymal transition by regulating ROS accumulation and autophagy disorder in endothelial cells. Redox Biol. 46, 102120 (2021).","journal-title":"Redox Biol."},{"key":"30454_CR28","doi-asserted-by":"publisher","first-page":"245","DOI":"10.3389\/fcell.2019.00245","volume":"7","author":"Z Li","year":"2019","unstructured":"Li, Z. et al. The chromatin remodeler Brg1 integrates ROS production and endothelial-mesenchymal transition to promote liver fibrosis in mice. Front Cell Dev Biol. 7, 245 (2019).","journal-title":"Front Cell Dev Biol."},{"key":"30454_CR29","unstructured":"Guide for the Care and Use of Laboratory Animals. 8th ed. 2011. The national academies collection: reports funded by national institutes of health."},{"key":"30454_CR30","doi-asserted-by":"publisher","first-page":"e3000410","DOI":"10.1371\/journal.pbio.3000410","volume":"18","author":"PN du Sert","year":"2020","unstructured":"du Sert, P. N. et al. The ARRIVE guidelines 20: Updated guidelines for reporting animal research. PLoS Biol. 18, e3000410 (2020).","journal-title":"PLoS Biol."},{"key":"30454_CR31","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1128\/jcm.26.10.2177-2179.1988","volume":"26","author":"TG Cleary","year":"1988","unstructured":"Cleary, T. G. & Murray, B. E. Lack of Shiga-like cytotoxin production by enteroinvasive Escherichia coli. J Clin Microbiol. 26, 2177\u20132179 (1988).","journal-title":"J Clin Microbiol."},{"key":"30454_CR32","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1007\/s10495-023-01860-2","volume":"28","author":"H Xu","year":"2023","unstructured":"Xu, H. et al. Glucocorticoid-induced activation of NOX\/ROS\/NF-kappaB signaling in MSCs contributes to the development of GONFH. Apoptosis 28, 1332\u20131345 (2023).","journal-title":"Apoptosis"},{"key":"30454_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2024.123929","volume":"653","author":"C Liu","year":"2024","unstructured":"Liu, C. et al. Selenium nanoparticles\/carboxymethyl chitosan\/alginate antioxidant hydrogel for treating steroid-induced osteonecrosis of the femoral head. Int J Pharm. 653, 123929 (2024).","journal-title":"Int J Pharm."},{"key":"30454_CR34","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1002\/ptr.8031","volume":"38","author":"H Jiang","year":"2024","unstructured":"Jiang, H. et al. Taxifolin-mediated Nrf2 activation ameliorates oxidative stress and apoptosis for the treatment of glucocorticoid-induced osteonecrosis of the femoral head. Phytother Res. 38, 156\u2013217 (2024).","journal-title":"Phytother Res."},{"key":"30454_CR35","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1186\/s13018-024-04775-z","volume":"19","author":"W Wang","year":"2024","unstructured":"Wang, W., Jiang, H., Yu, J., Lou, C. & Lin, J. Astaxanthin-mediated Nrf2 activation ameliorates glucocorticoid-induced oxidative stress and mitochondrial dysfunction and impaired bone formation of glucocorticoid-induced osteonecrosis of the femoral head in rats. J Orthop Surg Res. 19, 294 (2024).","journal-title":"J Orthop Surg Res."},{"key":"30454_CR36","doi-asserted-by":"publisher","DOI":"10.1002\/btm2.10644","volume":"9","author":"R Francescato","year":"2024","unstructured":"Francescato, R., Moretti, M. & Bersini, S. Endothelial-mesenchymal transition in skeletal muscle: Opportunities and challenges from 3D microphysiological systems. Bioeng Transl Med. 9, e10644 (2024).","journal-title":"Bioeng Transl Med."},{"key":"30454_CR37","doi-asserted-by":"publisher","first-page":"6962801","DOI":"10.1155\/2016\/6962801","volume":"2016","author":"D Medici","year":"2016","unstructured":"Medici, D. Endothelial-mesenchymal transition in regenerative medicine. Stem Cells Int. 2016, 6962801 (2016).","journal-title":"Stem Cells Int."},{"key":"30454_CR38","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1093\/cvr\/cvx253","volume":"114","author":"C Souilhol","year":"2018","unstructured":"Souilhol, C., Harmsen, M. C., Evans, P. C. & Krenning, G. Endothelial-mesenchymal transition in atherosclerosis. Cardiovasc Res. 114, 565\u2013577 (2018).","journal-title":"Cardiovasc Res."},{"key":"30454_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2021.153419","volume":"221","author":"M Falleni","year":"2021","unstructured":"Falleni, M., Tosi, D., Savi, F., Chiumello, D. & Bulfamante, G. Endothelial-mesenchymal transition in COVID-19 lung lesions. Pathol Res Pract. 221, 153419 (2021).","journal-title":"Pathol Res Pract."},{"key":"30454_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2021.105725","volume":"170","author":"N Parsamanesh","year":"2021","unstructured":"Parsamanesh, N. et al. Resveratrol and endothelial function: A literature review. Pharmacol Res. 170, 105725 (2021).","journal-title":"Pharmacol Res."},{"key":"30454_CR41","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/path.2277","volume":"214","author":"TA Wynn","year":"2008","unstructured":"Wynn, T. A. Cellular and molecular mechanisms of fibrosis. J Pathol. 214, 199\u2013210 (2008).","journal-title":"J Pathol."},{"key":"30454_CR42","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1161\/CIRCRESAHA.119.314813","volume":"124","author":"J Bischoff","year":"2019","unstructured":"Bischoff, J. Endothelial-to-mesenchymal transition. Circ Res. 124, 1163\u20131165 (2019).","journal-title":"Circ Res."},{"key":"30454_CR43","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1161\/ATVBAHA.114.303220","volume":"35","author":"KM Welch-Reardon","year":"2015","unstructured":"Welch-Reardon, K. M., Wu, N. & Hughes, C. C. A role for partial endothelial-mesenchymal transitions in angiogenesis?. Arterioscler Thromb Vasc Biol. 35, 303\u2013308 (2015).","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"30454_CR44","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1136\/annrheumdis-2016-210229","volume":"76","author":"M Manetti","year":"2017","unstructured":"Manetti, M. et al. Endothelial-to-mesenchymal transition contributes to endothelial dysfunction and dermal fibrosis in systemic sclerosis. Ann Rheum Dis. 76, 924\u2013934 (2017).","journal-title":"Ann Rheum Dis."},{"key":"30454_CR45","doi-asserted-by":"publisher","first-page":"H285","DOI":"10.1152\/ajpheart.00560.2006","volume":"292","author":"E O'Riordan","year":"2007","unstructured":"O\u2019Riordan, E. et al. Chronic NOS inhibition actuates endothelial-mesenchymal transformation. Am J Physiol Heart Circ Physiol. 292, H285\u2013H294 (2007).","journal-title":"Am J Physiol Heart Circ Physiol."},{"key":"30454_CR46","doi-asserted-by":"publisher","first-page":"F717","DOI":"10.1152\/ajprenal.00071.2008","volume":"295","author":"A Stoessel","year":"2008","unstructured":"Stoessel, A. et al. Indolent course of tubulointerstitial disease in a mouse model of subpressor, low-dose nitric oxide synthase inhibition. Am J Physiol Renal Physiol. 295, F717\u2013F725 (2008).","journal-title":"Am J Physiol Renal Physiol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-30454-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-30454-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-30454-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T15:03:52Z","timestamp":1767884632000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-30454-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,15]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["30454"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-30454-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,15]]},"assertion":[{"value":"6 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All procedures were performed in compliance with relevant laws and institutional guidelines and have been approved by the institutional ethics review board at the third Affiliated Hospital of Guangzhou University of Chinese Medicine. (PJ-KY-20220420-013, 2022-04-20). The privacy rights of human subjects have been observed and that informed consent was obtained for experimentation with human subjects. Animal experiments are approved by the Animal Experimentation Center of Guangzhou University of Chinese Medicine (20240717013).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"986"}}